These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37241068)

  • 21. Successful deceased donor kidney transplantation to a recipient with a history of COVID-19 treatment.
    Yoshinaga K; Araki M; Wada K; Hasegawa K; Sekito T; Miyake S; Watari S; Maruyama Y; Sadahira T; Nishimura S; Tanabe K; Takeuchi H; Nakashima Y; Kinomura M; Acosta H; Mitsui Y; Kubota R; Nakajima H; Edamura K; Kobayashi Y; Watanabe M; Watanabe T; Otsuka F; Wada J; Nasu Y
    J Infect Chemother; 2021 Jul; 27(7):1097-1101. PubMed ID: 33893036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful pediatric liver transplantation case with a positive SARS-CoV-2 test at the time of transplant.
    Shimizu S; Sakamoto S; Yamada M; Funaki T; Fukuda A; Uchida H; Okada N; Nakao T; Kodama T; Komine R; Shoji K; Baba C; Suzuki Y; Nakagawa S; Ogimi C; Kasahara M
    Hepatol Res; 2023 Jun; 53(6):569-573. PubMed ID: 36654476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The case of a liver-transplant recipient with severe acute respiratory syndrome coronavirus 2 infection who had a favorable outcome.
    Hayashi K; Ito Y; Yamane R; Yoshizaki M; Matsushita K; Kajikawa G; Kozawa T; Mizutani T; Shimizu Y; Nagano K; Tachi K; Yoshioka K; Goto H
    Clin J Gastroenterol; 2021 Jun; 14(3):842-845. PubMed ID: 33675512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 RNA positive pediatric organ donors: A case report.
    Clark JD; Albers EL; Albert JE; Berkman ER; Englund JA; Farris RWD; Johnson BA; Lewis-Newby M; McGuire J; Rogers M; Thompson HM; Wagner TA; Wells C; Yanay O; Zerr DM; Limaye AP
    Pediatr Transplant; 2023 Aug; 27(5):e14452. PubMed ID: 36518025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients.
    Rabinowich L; Grupper A; Baruch R; Ben-Yehoyada M; Halperin T; Turner D; Katchman E; Levi S; Houri I; Lubezky N; Shibolet O; Katchman H
    J Hepatol; 2021 Aug; 75(2):435-438. PubMed ID: 33892006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transplant of organs from donors with positive SARS-CoV-2 nucleic acid testing: A report from the organ procurement and transplantation network ad hoc disease transmission advisory committee.
    Goldman JD; Pouch SM; Woolley AE; Booker SE; Jett CT; Fox C; Berry GJ; Dunn KE; Ho CS; Kittleson M; Lee DH; Levine DJ; Marboe CC; Marklin G; Razonable RR; Taimur S; Te HS; Anesi JA; Fisher CE; Sellers MT; Trindade AJ; Wood RP; Zaffiri L; Levi ME; Klassen D; Michaels MG; La Hoz RM; Danziger-Isakov L
    Transpl Infect Dis; 2023 Feb; 25(1):e14013. PubMed ID: 36694448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Through Solid Organ Transplantation and Outcomes of Coronavirus Disease 2019 Among Recent Transplant Recipients.
    Free RJ; Annambhotla P; La Hoz RM; Danziger-Isakov L; Jones JM; Wang L; Sankthivel S; Levi ME; Michaels MG; Kuhnert W; Klassen D; Basavaraju SV; Kracalik IT
    Open Forum Infect Dis; 2022 Jul; 9(7):ofac221. PubMed ID: 35873294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 infection in adult liver transplantation recipients: a systematic review of risk factors for mortality and immunosuppression role.
    Giovinazzo F; Vaccaro A; Pascale MM; Cardella F; Frongillo F; Galiandro F; Sganga G; Agnes S
    Eur Rev Med Pharmacol Sci; 2023 Feb; 27(4):1695-1707. PubMed ID: 36876704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver transplant after SARS-CoV-2 infection: A systematic review.
    Nacif LS; Fernandes MR; Waisberg DR; Pinheiro RS; Rocha-Santos V; Galvão F; Andraus W; Carneiro-D'Albuquerque L
    Clinics (Sao Paulo); 2022; 77():100042. PubMed ID: 35870265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Donor and transplant candidate selection for solid organ transplantation during the COVID-19 pandemic.
    Galvan NTN; Moreno NF; Garza JE; Bourgeois S; Hemmersbach-Miller M; Murthy B; Timmins K; O'Mahony CA; Anton J; Civitello A; Garcha P; Loor G; Liao K; Shaffi A; Vierling J; Stribling R; Rana A; Goss JA
    Am J Transplant; 2020 Nov; 20(11):3113-3122. PubMed ID: 32524743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utilization and outcomes of deceased donor SARS-CoV-2-positive organs for solid organ transplantation in the United States.
    Schold JD; Koval CE; Wee A; Eltemamy M; Poggio ED
    Am J Transplant; 2022 Sep; 22(9):2217-2227. PubMed ID: 35730252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-Lung Solid Organ Transplantation From SARS-CoV-2-Positive Donors to Uninfected Recipients.
    Wade J; Petitpas KM; Dar W; Ali A; Radojevic JA; Lawlor MT; Hammond JA; Gluck J; Feingold AD; Jaiswal A; Ebcioglu Z; Einstein M; Morgan G; Emmanuel B; Ye X; Singh JU; Sotil EU; Swales C; Kent R; Richardson E; Cheema F; Serrano OK
    Transplant Proc; 2023 Oct; 55(8):1793-1798. PubMed ID: 37487863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.
    Nakamura Y; Hama K; Iwamoto H; Yokoyama T; Kihara Y; Konno O; Jojima Y; Shimazu M
    Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial.
    Grau-Pujol B; Camprubí D; Marti-Soler H; Fernández-Pardos M; Guinovart C; Muñoz J
    Trials; 2020 Jul; 21(1):688. PubMed ID: 32727613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of the COVID-19 outbreak on liver transplantation programs in Northern Italy.
    Maggi U; De Carlis L; Yiu D; Colledan M; Regalia E; Rossi G; Angrisani M; Consonni D; Fornoni G; Piccolo G; DeFeo TM
    Am J Transplant; 2020 Jul; 20(7):1840-1848. PubMed ID: 32330351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testing.
    Kaul DR; Valesano AL; Petrie JG; Sagana R; Lyu D; Lin J; Stoneman E; Smith LM; Lephart P; Lauring AS
    Am J Transplant; 2021 Aug; 21(8):2885-2889. PubMed ID: 33565705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
    Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
    Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
    González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
    Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of SARS-CoV-2-infected deceased organ donors: Should we always "just say no?".
    Kates OS; Fisher CE; Rakita RM; Reyes JD; Limaye AP
    Am J Transplant; 2020 Jul; 20(7):1787-1794. PubMed ID: 32400087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.